Heimdall Insights

Global Kaposi Sarcoma Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Kaposi Sarcoma Market was valued at $150 mn. in 2025. During the forecast period 2025-2030, it is expected to grow at 4.5% CAGR, to an estimated market size of $187 mn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global Kaposi Sarcoma market encompasses the diagnostic solutions and therapeutic interventions designed to treat a rare cancer originating from the cells lining blood or lymph vessels. The scope includes chemotherapy, highly active antiretroviral therapy (HAART), immunotherapy, and targeted therapies specifically for populations affected by the Kaposi sarcoma-associated herpes virus (KSHV/HHV8), primarily including HIV/AIDS patients, organ transplant recipients, and other immunocompromised individuals.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Kaposi Sarcoma Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Middle East & Africa

Segments

  • Chemotherapy
  • Antiviral Therapy (HAART)
  • Immunotherapy & Targeted Therapy
  • Others